Top news from February: Coronavirus complications, women’s heart health and more
Click Here to Manage Email Alerts
Healio and Cardiology Today have compiled a list of the most-read news published in February.
Last month, readers were most interested in a study that demonstrated lifestyle habits may slip after initiation of statin or antihypertensive medications; a bulletin from the American College of Cardiology on the cardiac complications of coronavirus; an “At Issue” for which our team asked leaders in cardiology about the most important issues in women’s heart health today; and much more.
See below for Healio’s February highlights.
Lifestyle habits may slip after preventive medication initiation
Some patients who initiated statin or antihypertensive medications made unfavorable lifestyle changes such as gaining weight and participating in less physical activity, according to a study published in the Journal of the American Heart Association. Read more
ACC: Coronavirus has cardiac implications, especially in existing CVD
The American College of Cardiology released a bulletin on the cardiac implications of the coronavirus emphasizing the importance of advising patients with CVD on their potential increased risk for the virus. Read more
At Issue: Early risk identification, addressing disparities key for women’s heart health
In support of American Heart Month and National Wear Red Day in February, Healio and Cardiology Today asked leaders in the field to discuss the most important issues in women’s heart health today. Read more
Omega-3 fatty acids for CV risk reduction: The one that did not get away
The February issue of Cardiology Today features a Pharmacology Consult on omega-3 fatty acids for CV risk reduction. Read more
Paper on e-cigarette use and MI risk retracted
A study published in the Journal of the American Heart Association in June 2019 concluding that patients who smoked electronic cigarettes every day or some days had an increased risk for MI was retracted on Feb. 18, 2020. Read more
Rise in gut microbial metabolite may elevate CHD risk
Healthy women with long-term changes in plasma trimethylamine N-oxide, a choline metabolite produced from gut microbiota, had an increased risk for CHD, which may be modified by healthy dietary patterns, according to a prospective, nested, case-control study published in the Journal of the American College of Cardiology. Read more
Dapagliflozin reduces AF events in high-risk patients with diabetes
High-risk patients with diabetes who were treated with dapagliflozin had a decrease in the incidence of atrial fibrillation and atrial flutter, according to an analysis of the DECLARE-TIMI 58 trial published in Circulation. Read more
Type of shingles vaccine cuts stroke risk by 16% in elderly
A type of herpes zoster vaccine reduced risk for stroke in Medicare beneficiaries aged at least 66 years, according to findings presented at the International Stroke Conference. Read more
FDA approves bempedoic acid for LDL lowering in high-risk populations
The FDA has approved bempedoic acid and bempedoic acid/ezetimibe for reducing LDL as an adjunct to diet and maximally tolerated statin therapy in patients with heterozygous familial hypercholesterolemia or established atherosclerotic CVD. Read more
FDA authorizes marketing of software that uses artificial intelligence for cardiac diagnostics
The FDA granted Caption Health Inc. authorization to market its Caption Guidance software, which is intended to guide medical professionals through cardiac ultrasound image acquisition, according to an FDA release. Read more